Aerpace promoter trust infuses ₹48.82 cr via warrants, PNB adds ₹70 cr line

Tipsheet Editorial — Thu, 09 Jul 2026 18:19:04 GMT

Pre-revenue nano-cap gets 11%+ capital infusion from NK Family Private Trust and a ₹70 crore facility from Punjab National Bank, alongside seasoned advisor appointments.

What’s new

Board approved 1.5 crore convertible warrants at ₹32.55 each to promoter trust NK Family Private Trust, raising ₹48.82 cr.
Credit facility of ₹70 crore secured from Punjab National Bank for working capital.
Former SBI chairman Rajnish Kumar appointed as board advisor; Ms. Anshu Shukla Pandey joins as independent director.

Why it matters

For a company with zero revenue and a ₹9 crore quarterly loss, a ₹48.82 crore promoter-led infusion plus a ₹70 crore bank line is a vote of confidence that changes the balance sheet. The warrants require 25% upfront, so cash is coming in now. Rajnish Kumar's presence adds governance weight to a nano-cap that needs it.

What we’re watching

Conversion timeline: warrants can be exercised within 18 months, diluting equity at ₹32.55.
How the ₹70 crore PNB facility is deployed; working capital needs for a pre-revenue firm.
Whether the company gives revenue guidance in the next quarterly update.

The full read

Aerpace Industries has zero revenue and a ₹9 crore quarterly loss, yet its board just approved a ₹48.82 crore warrant issue to promoter trust NK Family Private Trust and secured a ₹70 crore credit line from PNB. The warrants ( 1.5 crore at ₹32.55 each) represent an 11%+ capital infusion relative to market cap. They are convertible within 18 months and require 25% upfront, which brings immediate cash. The parallel PNB facility nearly doubles the available liquidity. The appointments of former SBI chairman Rajnish Kumar as advisor and a new independent director add governance heft. For a nano-cap with no top line, structured capital from promoters and a bank is rare. The test now is whether Aerpace can deploy this into revenue.

Primary source: BSE · NSE

Aerpace board to weigh preferential issue, no details yet

Tipsheet Editorial — Mon, 06 Jul 2026 17:49:37 GMT

The micro-cap company's board meets July 9 to consider issuing equity or convertible warrants. Size, price, and investor remain unknown, keeping the move a placeholder until specifics emerge.

What’s new

Board meeting scheduled for July 9 to consider preferential issue of equity or convertible warrants.
No details on size, price, or potential investor disclosed in the exchange notice.
Trading window closed from July 1 until 48 hours after quarterly results.

Why it matters

For a micro-cap with negative PAT growth, any dilutive fundraising can shift ownership and earnings per share. But without specifics, this is a placeholder. The real signal comes when terms are revealed. The opacity itself is a watchpoint.

What we’re watching

July 9 board outcome: size, pricing, and whether a promoter or outsider subscribes.
Post-meeting disclosure: will the company quantify the dilution?
Quarterly results: the next catalyst after the preferential proposal.

The full read

Aerpace Industries' board will meet on July 9 to consider issuing equity shares or convertible warrants on a preferential basis. That is all the company said. No size, no price, no investor. Hardly a news event. For a micro-cap with a ₹497 cr market cap and trailing net profit down 82%, any dilutive fundraising matters — but this disclosure is a procedural placeholder, not a concrete action. The trading window is closed until after quarterly results, so insiders are already in a blackout. If the company comes back with a firm number and a credible backer, the story changes. If it stays vague, this remains noise.

Primary source: BSE · NSE

Aerpace Industries Ltd. (AERPACE) — Tipsheet

Aerpace promoter trust infuses ₹48.82 cr via warrants, PNB adds ₹70 cr line

What’s new

Why it matters

What we’re watching

The full read

Aerpace board to weigh preferential issue, no details yet

What’s new

Why it matters

What we’re watching

The full read